The DEA and opponents have filed new briefs in the federal cannabis rescheduling hearing, shaping the future of marijuana policy and delivery laws nationwide.

DEA’s 2026 Drugs of Abuse update says no deaths from marijuana overdose and reflects federal moves toward Schedule III for certain cannabis products. Here’s what it means in practice.

A new Trump video praising CBD for older Americans sparked a market rally. Here’s what actually changed, what didn’t, and how DMV consumers and delivery operators should read the signal.

A December 18, 2025 executive order shifts cannabis from Schedule I to Schedule III. Here’s how that could reshape taxes, research, and patient access across the DMV.

Georgia regulators reportedly believe federal rescheduling opens the door to mailing medical cannabis. Here’s what that signals for delivery laws, compliance, and the DMV.

Pennsylvania’s House speaker says legalization is within reach next year if the state Senate shifts—raising big questions about delivery rules, licensing and compliance.

State regulators say DEA guidance is essential to align medical cannabis rules with the new Schedule III status—especially for delivery, labeling, and patient access across the DMV.

Pennsylvania’s path to adult-use cannabis may hinge on three Senate seats. Here’s what’s in play, what’s unknown—especially for delivery rules—and why the Mid‑Atlantic should watch.

Alabama’s health department dropped its opposition to federal marijuana rescheduling, per MJBizDaily. Here’s what changed, what’s unknown, and why DMV readers should care.

MJBizDaily reports roughly two-thirds of Missouri cannabis operators passed on DEA registration after federal rescheduling. Here’s what that choice could mean for compliance, delivery and the DMV.

A repeal push in Massachusetts carries national implications. Here’s how it could influence federal rescheduling—and what DC, Maryland, and Virginia should watch now.

Two federal marijuana sentences were cut as Washington debates moving some cannabis to Schedule III. Here’s what’s known now—and what DMV residents should watch.

NCIA’s 14th Lobby Days landed after DOJ’s April order moving state‑regulated medical cannabis to Schedule III. Here’s what Congress heard—and what DMV consumers and delivery operators should watch.